MYO
Myomo, Inc.
MYO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has a slight edge over MYO overall, supported by lower modeled downside and stronger modeled upside.
MYO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
MYO's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MYO PE Valuation
MYO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MYO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
MYO has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MYO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.35 | -$0.07 |
| Q2 2026 | -$0.34 | -$0.12 |
| Q1 2026 | -$0.36 | -$0.22 |
| Q4 2025 | -$0.37 | -$0.21 |
| Q3 2025 | -$0.28 | -$0.05 |
| Q2 2025 | -$0.22 | +$0.04 |
| Q1 2025 | -$0.14 | +$0.13 |
| Q4 2024 | -$0.16 | +$0.12 |
MYO is still losing money, but far less than before: $0.35 per share over the past year, against $19.35 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MYO on earnings quality, reporting a profit while its opponent remains loss making.
MYO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.3M | +22% |
| Q2 2026 | $11.7M | +21% |
| Q1 2026 | $10.1M | +2.9% |
| Q4 2025 | $11.4M | -5.9% |
| Q3 2025 | $10.1M | +9.6% |
| Q2 2025 | $9.7M | +28% |
| Q1 2025 | $9.8M | +162% |
| Q4 2024 | $12.1M | +154% |
MYO has the edge over UNH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -14% | +21 points |
| Q2 2026 | -19% | +28 points |
| Q1 2026 | -31% | +4.6 points |
| Q4 2025 | -24% | -22 points |
| Q3 2025 | -35% | -25 points |
| Q2 2025 | -48% | -33 points |
| Q1 2025 | -36% | +68 points |
| Q4 2024 | -2% | +49 points |
MYO's operating margin was −14% last quarter, up 21 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MYO on profitability, with a higher operating margin.
MYO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$1.5M |
| Q2 2026 | -$2M | +$8.1M |
| Q1 2026 | -$2.5M | +$822.4K |
| Q4 2025 | $98.1K | -96% |
| Q3 2025 | -$2.9M | -$1.1M |
| Q2 2025 | -$10.1M | -$8.1M |
| Q1 2025 | -$3.3M | -$42.2K |
| Q4 2024 | $2.5M | +$4.9M |
MYO has burned cash in almost every quarter: −$6M over the past year, against −$14M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MYO on cash generation, producing positive trailing cash flow while its opponent burns cash.
MYO Net Leverage
MYO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MYO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 20.7 | Neutral |
MYO's weekly RSI is 48 (neutral) and its Stochastic is 21 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MYO PE vs Healthcare Sector
MYO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MYO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 9.7% below |
| 20 week MA | $1.32 | 8.3% below |
| 50 week MA | $1.08 | 12% above |
| 100 week MA | $2.14 | 43% below |
| 200 week MA | $2.36 | 49% below |
MYO's trend is mixed: it's above one of its five weekly moving averages, and 49% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MYO on trend strength, trading above more of its moving averages.
MYO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.08 | $6.94 | -24% |
| 2021 | $6.94 | $7.90 | +14% |
| 2022 | $7.90 | $0.44 | -94% |
| 2023 | $0.44 | $5.01 | +1039% |
| 2024 | $5.01 | $6.37 | +27% |
| 2025 | $6.37 | $1.02 | -84% |
| 2026 YTD | $1.02 | $1.21 | +19% |
MYO's yearly returns have swung widely, from +1039% in 2023 to −94% in 2022. It's up 19% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MYO on returns for 2026, with the stronger performance.